Skip to content
The Policy VaultThe Policy Vault

sorafenib generic — Cigna

Ovarian Cancer

Initial criteria

  • Patient age ≥ 18 years
  • Patient has platinum-resistant disease
  • Sorafenib is used in combination with topotecan

Approval duration

1 year